SAP30 and breast cancer: At postnatal day 155, we harvested mammary tumors from these mouse models and found that both total tumor number and weight were significantly reduced in SAP30-homozygous-KO mice compared with SAP30-WT or heterozygous mice (Figure 3, E and F).